Clinical Trials Logo

Multiple Sclerosis clinical trials

View clinical trials related to Multiple Sclerosis.

Filter by:

NCT ID: NCT05543213 Recruiting - Multiple Sclerosis Clinical Trials

The Effects of Action Observation Therapy (AOT) on Balance and Gait in Patients With Multiple Sclerosis.

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Action observation therapy is a new method in rehabilitation that causes motor retraining by activating mirror neurons while watching the activity on the screen and then practicing them. We will use action observation therapy to improve balance and walking in MS patients.

NCT ID: NCT05541965 Recruiting - Multiple Sclerosis Clinical Trials

The Effect of Reflexology and Pelvic Floor Muscle Exercises (Kegel) on Urinary Incontinence in MS Patients

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

The research was carried out as experiment, control group, pretest-posttest model and single-blind. The population of the study consisted of MS patients who applied to OMU (Ondokuz Mayıs University) Neurology Service and Neurology Outpatient Clinic between March 2020 and February 2022. Fifteen patients who met the inclusion criteria were included in the study. Patients were divided into reflexology, pelvic floor muscle exercise and control groups. The control group was not intervened, only data collection tools were applied.

NCT ID: NCT05539729 Recruiting - Multiple Sclerosis Clinical Trials

Vancomycin Study in Multiple Sclerosis (MS)

Start date: February 8, 2023
Phase: Phase 1
Study type: Interventional

The overall goal of this study is to elucidate a mechanism by which vancomycin modulates the gut-brain axis in multiple sclerosis (MS). The gut microbiome plays an important role in autoimmunity, including MS. However, the identity of gut microbes modulating neuroinflammation in MS and their mechanisms of action remain obscure. Hence, here the research team proposes to investigate the effects of vancomycin on the gut microbiota composition, peripheral immune function, and brain MRI lesions in MS patients.

NCT ID: NCT05533905 Completed - Multiple Sclerosis Clinical Trials

DECISIve - DiagnosE Using the Central veIn SIgn v1.0

DECISiVE
Start date: December 9, 2019
Phase:
Study type: Observational

DECISIve - DiagnosE using the Central veIn SIgn. A prospective diagnostic superiority study comparing T2* MRI and lumbar puncture in patients presenting with possible Multiple Sclerosis

NCT ID: NCT05532943 Recruiting - Multiple Sclerosis Clinical Trials

Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis

UMSC01
Start date: September 8, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This study is to identify the safety and efficacy of repeat IV(Intravenous) and IT(Intrathecal) administrations of UMSC01 in patients with MS. While anti-inflammatory drugs are routinely used for the treatment of MS by inhibiting immune responses, their effects on axon remyelination or neuroregeneration are limited. The combined systemic delivery of UCMSCs via intravenous injection and local administration of the cells by IT was to have safety and therapeutic efficacy for patients with MS.

NCT ID: NCT05532163 Terminated - Clinical trials for Multiple Sclerosis, Relapsing-Remitting

A Study to Investigate the Radiological Onset of Action After Treatment Initiation With Subcutaneous (SC) Natalizumab in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Start date: January 23, 2023
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to evaluate the radiological efficacy of SC natalizumab over time through Week 24 in natalizumab-naïve participants, as measured by brain magnetic resonance imaging (MRI). The secondary objectives of this study are to evaluate additional lesion-related radiological efficacy measures over time, relapse-based clinical efficacy measures, disability improvement and worsening (EDSS), pharmacokinetic and pharmacodynamic parameters, the immunogenicity of repeated doses, and safety in treatment-naïve participants of SC natalizumab.

NCT ID: NCT05529498 Recruiting - Clinical trials for Multiple Sclerosis,Gait, Exercise

High Intensity Interval Gait Training in Multiple Sclerosis

Start date: September 2, 2022
Phase: N/A
Study type: Interventional

Over 90% of persons with MS (pwMS) complain of difficulty with walking. High intensity interval gait training (HIIGT), where persons alternate brief periods of walking at high speeds with periods of rest has been found to improve walking in other neurologic diagnoses. However its impact on pwMS is not known. Most gait training in MS is done continuously at a slower pace. The purpose of this study is to compare the effects of HIIGT to traditional Moderate Intensity Continuous Gait Training (MICGT) in pwMS.

NCT ID: NCT05528666 Completed - Multiple Sclerosis Clinical Trials

Risk Perception in Multiple Sclerosis

Start date: September 9, 2021
Phase:
Study type: Observational

This study was a retrospective, non-interventional, cross-sectional, multi-cohort study of patients clinically diagnosed with RMS (RRMS and SPMS). Patients were classified according to the immediate previous treatment in two groups, those who were prescribed with high efficacy treatments (HETs) and those who were prescribed with non-high efficacy treatments (non-HETs). HET include alemtuzumab, ofatumumab, ocrelizumab, natalizumab, cladribine, fingolimod and ozanimod; and non-HETs include molecules classified as with moderate or modest efficacy such as: interferons, glatiramer acetate, dimethyl fumarate and teriflunomide.

NCT ID: NCT05526287 Recruiting - Multiple Sclerosis Clinical Trials

Effects of Dual-Task Training in People With Multiple Sclerosis

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of dual task training on balance, gait, dual-task performance, cognitive function, fatigue and functional mobility in people with Multiple Sclerosis(MS).

NCT ID: NCT05523466 Not yet recruiting - Multiple Sclerosis Clinical Trials

Effect of Acupuncture on Heart Rate Variability in Multiple Sclerosis

Start date: December 2022
Phase: N/A
Study type: Interventional

The Objective of this study is to evaluate the heart rate variability in individuals with multiple sclerosis during the applicability of Acupuncture, to analyze the behavior of the autonomic nervous system before, during, and after therapy and the changes of the condition.